SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007449
Filing Date
2022-05-05
Accepted
2022-05-05 17:16:15
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20220331x10q.htm   iXBRL 10-Q 1755655
2 EX-31.1 iova-20220331xex31d1.htm EX-31.1 12334
3 EX-31.2 iova-20220331xex31d2.htm EX-31.2 12221
4 EX-32.1 iova-20220331xex32d1.htm EX-32.1 7089
5 EX-32.2 iova-20220331xex32d2.htm EX-32.2 7161
6 GRAPHIC iova-20220331x10q001.jpg GRAPHIC 87042
  Complete submission text file 0001558370-22-007449.txt   7270738

Data Files

Seq Description Document Type Size
7 EX-101.SCH iova-20220331.xsd EX-101.SCH 43390
8 EX-101.CAL iova-20220331_cal.xml EX-101.CAL 51102
9 EX-101.DEF iova-20220331_def.xml EX-101.DEF 212865
10 EX-101.LAB iova-20220331_lab.xml EX-101.LAB 348236
11 EX-101.PRE iova-20220331_pre.xml EX-101.PRE 318750
59 EXTRACTED XBRL INSTANCE DOCUMENT iova-20220331x10q_htm.xml XML 1282455
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 22897701
SIC: 2836 Biological Products, (No Diagnostic Substances)